What is the best anti-vascular endothelial growth factor agent for the treatment of diabetic macular edema？ Review of the 2-year results of Diabetic Retinopathy Clinical Research Network ProtocolT
What is the best anti-vascular endothelial growth factor agent for the treatment of diabetic macular edema? Review of the 2-year results of Diabetic Retinopathy Clinical Research Network Protocol T作者机构：Department of Ophthalmology Rabin Medical Center Sackler School of Medicine Tel Aviv University Tel Aviv Israel
出 版 物：《Eye Science》 (眼科学报（英文版）)
年 卷 期：2016年第31卷第4期
页 面：217-220页
学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 100212[医学-眼科学] 10[医学]
主 题：糖尿病视网膜病变 血管内皮生长因子 早期治疗 病性 网络协议 水肿 黄斑 业绩
摘 要：Diabetic macular edema(DME) remains a main concern in diabetic patients,due to potential visual impairment with any level of diabetic *** first study to provide a treatment option for these patients was The Early Treatment Diabetic Retinopathy Study(ETDRS),
维普期刊数据库
同方期刊数据库